Miyazawa et al. found that pioglitazone inhibited PPAT inflammation in obese mice, reduced the density of CLS in periprostatic fat, and inhibited the levels of TNF-α, TGF-β, and chemokine monocyte chemotactic protein-1 (MCP-1), thus improving PCa 69. Here, CCL2 is linked to posterior cortical atrophy.